Literature DB >> 33738048

Novel Oxazine Monoacylglycerol Lipase (MAGL) Inhibitors.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33738048      PMCID： PMC7957918          DOI： 10.1021/acsmedchemlett.1c00055

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Monoacylglycerol lipase (MAGL) as a promising therapeutic target.

Authors:  Ana Gil-Ordóñez; Mar Martín-Fontecha; Silvia Ortega-Gutiérrez; María L López-Rodríguez
Journal:  Biochem Pharmacol       Date:  2018-07-27       Impact factor: 5.858

Review 2.  Lipase Inhibitors for Obesity: A Review.

Authors:  Tian-Tian Liu; Xiao-Tian Liu; Qing-Xi Chen; Yan Shi
Journal:  Biomed Pharmacother       Date:  2020-05-30       Impact factor: 6.529

Review 3.  Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.

Authors:  Natasha L Grimsey; Juha R Savinainen; Bala Attili; Muneer Ahamed
Journal:  Drug Discov Today       Date:  2019-10-14       Impact factor: 7.851

Review 4.  Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.

Authors:  Hui Deng; Weimin Li
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.